Alternative splicing and residual function potentially expand the therapeutic landscape of the CFTRdele2ins182 variant. Pastorino C, Menta L, Pesce E, Lena M, et al. PLoS One 2025;20:e0330974.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pastorino C, Menta L, Pesce E, Lena M, et al. Alternative splicing and residual function potentially expand the therapeutic landscape of the CFTRdele2ins182 variant. PLoS One 2025;20:e0330974.
PMID: 40956828